phosphotyrosine has been researched along with B-Cell Leukemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Efremov, DG; Gobessi, S; Laurenti, L; Leone, G; Longo, PG; Sica, S | 1 |
Hamaguchi, T; Osada, H; Sudo, T | 1 |
Aruffo, A; Blake, J; Chan, PY; Cosand, WL; Kanner, SB; Neubauer, MG; Whitney, GS | 1 |
de Aos, IE; Ilaria, RL; Roumiantsev, S; Van Etten, RA; Varticovski, L | 1 |
4 other study(ies) available for phosphotyrosine and B-Cell Leukemia
Article | Year |
---|---|
ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.
Topics: Adaptor Proteins, Signal Transducing; Enzyme Activation; Humans; Leukemia, B-Cell; Ligands; Lymphoma, B-Cell; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-cbl; Receptors, Antigen, B-Cell; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tumor Cells, Cultured; ZAP-70 Protein-Tyrosine Kinase | 2007 |
RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1phase.
Topics: Aniline Compounds; Antifungal Agents; Blotting, Western; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Dual Specificity Phosphatase 3; Enzyme Inhibitors; Ethers, Cyclic; G1 Phase; Humans; Kinetics; Leukemia, B-Cell; Okadaic Acid; Organophosphorus Compounds; Phosphoprotein Phosphatases; Phosphoproteins; Phosphotyrosine; Protein Tyrosine Phosphatases; Pyrans; Spiro Compounds; Streptomyces; Tumor Cells, Cultured; Vanadates | 1995 |
Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK.
Topics: Amino Acid Sequence; Animals; B-Lymphocytes; Base Sequence; Cell Adhesion Molecules; Chickens; Cloning, Molecular; DNA, Complementary; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Humans; In Vitro Techniques; Leukemia, B-Cell; Leukemia, T-Cell; Mice; Molecular Sequence Data; Phosphotyrosine; Protein-Tyrosine Kinases; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; T-Lymphocytes; Tumor Cells, Cultured; Tyrosine | 1993 |
The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase.
Topics: Animals; Bone Marrow Cells; Cell Line; Cell Transformation, Neoplastic; Disease Models, Animal; Enzyme Activation; Female; Fusion Proteins, bcr-abl; Interleukin-3; Leukemia, B-Cell; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred BALB C; Myeloid Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotyrosine; Point Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Signal Transduction; src Homology Domains; Stem Cells | 2001 |